Macrovascular disease and hyperglycaemia: 10-year survival analysis in type 2 diabetes mellitus: The belfast diet study

Diabetic Medicine

Volumn 14, Issue 8, 1997, Pages 663-672

  Hadden, D R ^a   Patterson, C C ^b   Atkinson, A B ^a   Kennedy, L ^c   Bell, P M ^a   McCance, D R ^a   Weaver, J A ^a  

^a ROYAL VICTORIA HOSPITAL   (United Kingdom)

^b QUEEN'S UNIVERSITY BELFAST   (United Kingdom)

^c UNIVERSITY OF NORTH CAROLINA AT CHARLOTTE   (United States)

Author keywords

Cerebrovascular accident; Hyperglycaemia; Mortality; Myocardial infarction; Non insulin dependent (Type 2) diabetes mellitus

Indexed keywords

GLUCOSE; INSULIN;

ADULT; ARTICLE; BODY WEIGHT; CEREBROVASCULAR ACCIDENT; DIABETIC ANGIOPATHY; DIET THERAPY; FEMALE; FOLLOW UP; GLUCOSE BLOOD LEVEL; HEART INFARCTION; HUMAN; HYPERGLYCEMIA; MAJOR CLINICAL STUDY; MALE; MORBIDITY; MORTALITY; NON INSULIN DEPENDENT DIABETES MELLITUS; RISK ASSESSMENT; SMOKING; STATISTICAL ANALYSIS; SYSTOLIC BLOOD PRESSURE;

ADULT; AGED; BLOOD GLUCOSE; CARDIOVASCULAR DISEASES; CEREBROVASCULAR DISORDERS; DIABETES MELLITUS, TYPE 2; FEMALE; FOLLOW-UP STUDIES; HUMANS; HYPERGLYCEMIA; MALE; MIDDLE AGED; NORTHERN IRELAND; PROSPECTIVE STUDIES; SURVIVAL ANALYSIS;

EID: 0030747672     PISSN: 07423071     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1096-9136(199708)14:8<663::AID-DIA450>3.0.CO;2-Y     Document Type: Article

References (37)

1. Hadden DR, Blair ALT, Wilson EA, Boyle DMcC, Atkinson AB, Kennedy AL, et al. Natural history of diabetes presenting age 40-69 years: a prospective study of the influence of intensive dietary therapy. Quart J Med 1986; 59: 579-598.
2. Hadden DR, Montgomery DAD, Skelly RJ, Trimble ER, Weaver JA, Wilson EA, et al. Maturity onset diabetes mellitus: response to intensive dietary therapy. Br Med J 1975; 2: 276-278.
3. Wilson EA, Hadden DR, Merrett JD, Montgomery DAD, Weaver JA. Dietary management of maturity onset diabetes. Br Med J 1980; 3: 1367-1369.
4. Hadden DR, Wilson EA, Dietary management of diabetes mellitus. Proc Nutr Soc 1980; 40: 247-255.
5. Lyons TJ, Kennedy L, Atkinson B, Buchanan K, Hadden DR, Weaver JA. Predicting the need for insulin therapy in late onset (40-69 years) diabetes mellitus. Diabetic Med 1984; 1: 105-107.
6. Archbold GPR, Lavery TD, Kennedy L, Atkinson AB, Hadden DR. Effect of dietary therapy on serum HDL-cholesterol and other lipids in type 2 diabetes - a prospective study over 6 years. Ann Clin Biochem 1987; 24(suppl 1): 141-142.
7. Boyle D, Bhatia SK, Hadden DR, Montgomery DAD, Weaver JA. Ischaemic heart disease in diabetics. Lancet 1972; 1: 338-339.
8. Hill ID. Computing man years at risk. Br J Prev Soc Med 1972; 26: 132-134.
9. Berry C. The analysis of mortality by the subject-years method. Biometrics 1983; 39: 173-184.
10. SAS Institute. SAS/STAT User's Guide. Version 6, Cary, North Carolina: SAS Institute, 1989.
11. University Group Diabetes Program. A study of the effects of hypoglycaemic agents on vascular complications in patients with adult-onset diabetes: II. Mortality results. Diabetes 1970; 19 (suppl 2): 785-830.
12. Hadden DR, Montgomery DAD, Weaver JA. Myocardial infarction in maturity onset diabetics. A retrospective study. Lancet 1972; 1: 335-338.
13. Boyle D, Bhatia SK, Hadden DR, Montgomery DAD, Weaver JA. Ischaemic heart disease in diabetics. Lancet 1972; 1: 338-339.
14. United Kingdom Prospective Diabetes Study UKPDS. viii: Study design, progress and performance. Diabetologia 1991; 34: 877-890.
15. Joint Discussion, The International Collaborative Group. Is asymptomatic hyperglycaemia a risk factor for the atherosclerotic diseases? J Chron Dis 1979; 32: 829-837.
16. Panzram G. Mortality and survival in Type 2 (non-insulin-dependent) diabetes mellitus. Diabetologia 1987; 30: 123-131.
17. Sartar G, Schersten B, Carlstrom S, Melander A, Norden A, Persson G. Ten year follow up of subjects with impaired glucose tolerance. Prevention of diabetes by tolbutamide and diet regulation. Diabetes 1980; 29: 41-49.
18. Jarrett RJ, McCartney P, Keen H. The Bedford Survey: ten year mortality rates in newly diagnosed diabetics, borderline diabetics and normoglycaemic controls, and risk indices for coronary heart disease in borderline diabetics. Diabetologia 1982; 22: 79-84.
19. Fuller JH, Shipley MJ, Rose G, Jarrett RJ, Keen H. Mortality for coronary heart disease and stroke in relation to degree of glycaemia: the Whitehall study. Br Med J 1983; 287: 867-870.
20. Eschwege E, Richard JL, Thibult H, Ducimetiere P, Warnet JM, Claude JR, Rosselin GE. Coronary heart disease mortality in relation with diabetes, blood glucose and plasma insulin levels. The Paris prospective study, ten years later. Horm Metab Res 1985; 15(suppl): 41-46.
21. Sonksen PH, Lowy C, Perkins JR, Lim HS. Non-insulin dependent diabetes: 10 year outcome in relation to initial response to diet and subsequent sulphonylurea therapy. Diabetes Care 1984: 7 (suppl 1): 59-66.
22. Coppack SW, Doll HA, Pim B, Hockaday TDR. Intravenous glucose tolerance and mortality in non-insulin dependent diabetes mellitus. Quart J Med 1990; 75: 451-460.
23. Coppack SW, Yajuik CS, Doll HA, Thursfield V, Hockaday TDR. The metabolic associations of intravenous glucose tolerance in the 10 years from diagnosis of Type 2 diabetes. Diabetic Med 1990; 7: 718-724.
24. Rudenski AS, Hadden DR, Atkinson AB, Kennedy L, Matthews DR, Merrett JD, et al. Natural history of pancreatic islet β-cell function in Type 2 diabetes mellitus studied over six years by homeostasis model assessment. Diabetic Med 1988; 5: 36-41.
25. Uusitupa MIJ, Niskanen LK, Siitonen O, Voutilainen E, Pyorala K. Ten year cardiovascular mortality in relation to risk factors and abnormalities in lipoprotein composition in type 2 (non-insulin-dependent) diabetic and non-diabetic subjects. Diabetologia 1993; 36: 1175-1184.
26. Moss SE, Klein R, Klein BE, Mener SM. The association of glycemia and cause-specific mortality in a diabetic popoulation. Arch Intern Med 1994; 154: 2473-2479.
27. 1 measurement superfluous in NIDDM? Diabetes Care 1988; 111: 512-514.
28. Kuusisto J, Mykkanen L, Pyorala K, Laakso M. NIDDM and its metabolic control predict coronary heart disease in elderly subjects. Diabetes 1994; 43: 960-967.
29. Andersson DKG, Svardsudd K. Long-term glycemic control relates to mortality in type II diabetes. Diabetes Care 1995; 18: 1534-1543.
30. Head J, Fuller JH. International variations in mortality among diabetic patients: the WHO multinational study of vascular disease in diabetics. Diabetologia 1990; 33: 477-481.
31. Waugh NR, Dallas JH, Jung RT, Newton RW. Mortality in a cohort of diabetic patients. Causes and relative risks. Diabetologia 1989; 32: 103-104.
32. Sprafka JM, Paukow J, McGovern PG, French LR. Mortality among Type 2 diabetic individuals and associated risk factors: the three city study. Diabetic Med 10: 627-632.
33. Wong JSK, Pearson DWM, Murchison LE, Williams MJ, Narayan V. Mortality in diabetes mellitus: experience of a geographically defined population. Diabetic Med 1991: 8: 135-139.
34. Holmes J, Hadden DR, Atkinson AB, Kennedy AL, Wilson EA. Assessment of diet adherence in relation to long-term follow up of non-insulin-dependent diabetics. Practical Diabetes 1987; 4: 276-278.
35. O'Rahilly SP, Rudenski AS, Burnett MA, Nugent Z, Hosker JP, Darling P, Turner RC. Beta-cell dysfunction, rather than insulin insensitivity, is the primary defect in familial type 2 diabetes. Lancet 1986; iii: 360-364.
36. Yarnell JWG, Pickering JE, Elwood PC, Baker IA, Bainton D, Dawkins C, Phillips DIW. Does non-diabetic hyperglycaemia predict future IHD? Evidence from the Caerphilly and Speedwell studies. J Clin Epidemiol 1994; 47: 383-388.
37. Currie CJ, Williams DRR, Peters JR. Patterns of in and out-patient activity for diabetes: a district survey. Diabetic Med 1996; 13: 273-280.